ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Low-Density Lipoprotein Receptor-Targeted Biomimetic Nanoplatform Suppresses Glioblastoma Stemness and Remodels Antitumor Immunity via Dual Metabolic Disruption.
Yining Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.